Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, BGI Tech Ink Database Distribution Agreement

NEW YORK (GenomeWeb) – Qiagen and BGI Tech Solutions said today that they have signed a distribution and service agreement that allows BGI Tech to provide services and support around Qiagen's Human Gene Mutation Database (HGMD) to customers in China.

Qiagen acquired HGMD when it purchased Biobase in May this year. HGMD is a comprehensive database of human inherited disease mutations for use in genetics and genomic research. Its features include over 152,000 mutation reports including specifics on genome coordinates, sequence details, and links to the source material. It also includes over 5,300 summary reports that cover known inherited disease mutations for various genes.

"Collaborating with Qiagen can enrich our scientific strengths in the fields of human genetics and complex diseases, and enable us to provide better services for our global collaborators," Yingrui Li, BGI Tech's CEO, said in a statement.

Frank Schacherer, Biobase's CTO, added that "new and existing HGMD customers in Greater China will benefit from local support and from a distributor with deep subject-matter expertise."

Financial and other terms of the agreement were not disclosed.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.